AU Patent

AU2006214454B2 — Dosage form and method for sustained release of a substituted pyrazine compound

Assigned to Jazz Pharmaceuticals Inc · Expires 2011-05-19 · 15y expired

What this patent protects

Patent listed against sodium-oxybate.

Drugs covered by this patent

Patent Metadata

Patent number
AU2006214454B2
Jurisdiction
AU
Classification
—
Expires
2011-05-19
Drug substance claim
No
Drug product claim
No
Assignee
Jazz Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.